Disclosures for "Clinical Journey of Patients with Early/Typical-onset Friedreich Ataxia: A Real-world U.S. Claims Perspective"
-
Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Henriquez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Henriquez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
-
Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
-
Dr. DiDonato has received personal compensation for serving as an employee of Biogen.
-
Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
-
Ms. Ip has nothing to disclose.
-
Ms. Ma has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Komodo Health.
-
Dr. Chen has nothing to disclose.
-
Dr. McKay has received personal compensation for serving as an employee of Biogen. Dr. McKay has stock in Biogen.
-
Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
-
Dr. Ghosh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ghosh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.